
Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Pimavanserin offers a serotonin-targeted option for Parkinson disease psychosis that improves hallucinations and delusions with minimal impact on motor symptoms.

Published: December 25th 2025 | Updated:

Published: December 30th 2025 | Updated: